• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.

作者信息

Lopes Renato D, Fanaroff Alexander C

机构信息

Duke Clinical Research Institute, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina.

Penn Cardiovascular Outcomes, Quality and Evaluative Research Center, Leonard Davis Institute, and Cardiovascular Medicine Division, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J Am Coll Cardiol. 2020 Oct 20;76(16):1827-1829. doi: 10.1016/j.jacc.2020.09.008.

DOI:10.1016/j.jacc.2020.09.008
PMID:33059827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7550042/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d6/7550042/4083ef538baa/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d6/7550042/4083ef538baa/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d6/7550042/4083ef538baa/fx1_lrg.jpg

相似文献

1
Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.新型冠状病毒肺炎中的抗凝治疗：是时候获取高质量证据了。
J Am Coll Cardiol. 2020 Oct 20;76(16):1827-1829. doi: 10.1016/j.jacc.2020.09.008.
2
Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.
3
Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.3 例住院 COVID-19 患者抗凝预防治疗并发颅内出血。
J Neurovirol. 2020 Aug;26(4):602-604. doi: 10.1007/s13365-020-00869-6. Epub 2020 Jun 22.
4
Anticoagulation in COVID-19.新型冠状病毒肺炎中的抗凝治疗
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):260-261. doi: 10.1093/ehjcvp/pvaa036.
5
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
6
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
7
Problems related with anticoagulant usage during COVID-19 outbreak.2019冠状病毒病疫情期间与抗凝剂使用相关的问题。
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):695-696. doi: 10.1016/j.jvsv.2020.04.022. Epub 2020 May 12.
8
Anticoagulation in Hospitalized Patients with Covid-19.新冠病毒疾病住院患者的抗凝治疗
N Engl J Med. 2020 Oct 22;383(17):1675-1678. doi: 10.1056/NEJMclde2028217.
9
[Coagulopathies, thrombotic risk and anticoagulation in COVID-19].[新型冠状病毒肺炎中的凝血功能障碍、血栓形成风险与抗凝治疗]
Rev Med Liege. 2020;75(S1):86-93.
10
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.新型冠状病毒肺炎患者凝血功能障碍与抗凝药物之间的较量。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.

引用本文的文献

1
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants.新冠病毒病的最佳抗凝策略：预防性还是治疗性？：对超过27000名参与者的荟萃分析、试验序贯分析和荟萃回归分析
Emerg Crit Care Med. 2022 Sep;2(3):148-166. doi: 10.1097/EC9.0000000000000059. Epub 2022 Sep 16.
2
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.新冠病毒病（COVID-19）合并D-二聚体浓度升高住院患者的治疗性与预防性抗凝治疗（ACTION）：一项开放标签、多中心、随机对照试验
Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.
3

本文引用的文献

1
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.COVID-19 住院患者的抗凝、出血、死亡率和病理学。
J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826. doi: 10.1016/j.jacc.2020.08.041. Epub 2020 Aug 26.
2
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week.随机对照试验与常识和临床观察：JACC 本周综述主题。
J Am Coll Cardiol. 2020 Aug 4;76(5):580-589. doi: 10.1016/j.jacc.2020.05.069.
3
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.随机临床试验评估常规全抗凝策略在因冠状病毒感染（SARS-CoV2）住院的患者中的效果：ACTION（抗凝血冠状病毒）联盟 IV 试验的原理和设计。
Am Heart J. 2021 Aug;238:1-11. doi: 10.1016/j.ahj.2021.04.005. Epub 2021 Apr 20.
4
COVID-19 and Thromboinflammation: Is There a Role for Statins?COVID-19 与血栓炎症：他汀类药物有作用吗？
Clinics (Sao Paulo). 2021 Mar 24;76:e2518. doi: 10.6061/clinics/2021/e2518. eCollection 2021.
5
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.近期 COVID-19 患者抗血栓治疗的随机临床试验：美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Apr 20;77(15):1903-1921. doi: 10.1016/j.jacc.2021.02.035. Epub 2021 Mar 16.
2020 年新型冠状病毒病（COVID-19）患者抗栓治疗的循证实用指南。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936350. doi: 10.1177/1076029620936350.
4
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
5
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
6
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
7
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
8
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
9
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南：住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
10
Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.外科危重症患者的肝素预防血栓：随机试验的系统评价和荟萃分析。
Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104.